Medical Devices

Beyond the press release, MegaGen's investment in BIOLASE is a strategic masterclass in post-acquisition revival, aiming to dominate the dental tech market.

Johnson & Johnson's new platform combines RF and PF ablation, moving beyond the hype of single-modality tech to offer physicians unprecedented versatility.

IBA's deal to build Brazil's first proton therapy center is more than a medical breakthrough; it's a high-stakes play for market dominance in Latin America.

Discover how a strategic partnership is bridging the gap between cutting-edge diagnostic tools and the clinical expertise needed to save sight.

A new Arizona law modernizes radiation safety, allowing advanced technology to replace heavy lead aprons. It's a move that could ease a hidden physical toll on clinicians and reshape occupational wellness in healthcare nationwide.

LambdaVision and Vast are partnering to build artificial retinas in orbit, a key signal that the low-Earth orbit economy is ready for business.

As LivaNova preps its Q2 2026 report, all eyes are on its growth in neuromodulation and cardiac care. Will innovation continue to drive its success?

Incoming Nuwellis CEO Mike McCormick lays out a bold growth plan targeting critically ill children, but a closer look reveals a precarious financial balancing act.

With a seasoned med-tech innovator at the helm, Picard Medical's SynCardia faces a pivotal moment. Can it expand its life-saving artificial heart monopoly?

With a Wall Street veteran as CFO and a top cardiologist as advisor, Australian AI firm Echo IQ is executing a calculated assault on the U.S. healthcare market.

For decades, the delivery room has relied on ambiguous tech, fueling anxiety and unnecessary surgeries. Now, a new wearable system aims to finally provide clarity.

With a new patent for its AI-powered VVC device, Zero Candida is betting on smart technology to solve a persistent health issue where drugs often fail.

A new medical device just debuted in the U.S., but the real story is the strategy. How a small Arizona startup is using precision engineering to challenge giants.

A new partnership brings FDA-authorized home ultrasounds to virtual care, aiming to reach millions of women in 'maternity deserts' with vital prenatal monitoring.

Valgen Medtech's dual EU approval for its heart valve device isn't just a clinical win; it's a tremor in the global medical technology landscape.

With its U.S. launch underway, Nyxoah is betting its innovative Genio system can unseat an industry giant. But can it chart a path to profitability?

A medical breakthrough in neurostimulation could dramatically increase the supply of lungs for transplant, tackling a critical shortage and saving lives.

With 40M more patients now covered, Kerecis's fish-skin technology is set for accelerated adoption, driven by powerful clinical data and payor confidence.

A new generation of ultra-precise syringes is quietly enabling the future of gene therapy and neuroscience. Here’s why this small innovation is a giant leap.

Behind the acquisition of Harloff by Capsa Healthcare lies a story of market consolidation, where smart logistics are becoming as critical as the medicine itself.